News|Articles|September 14, 2026

Chirality Under the Microscope: What SFC Reveals About a Cancer-Fighting Ruthenium Complex

Daniel W. Armstrong explains how SFC confirmed mirror-image ruthenium photosensitiz-ers perform identically against melanoma cells.

Chiral metal complexes are getting a fresh look as potential drugs, but unlike organic drug candidates, their "handedness," or chirality, rarely gets the same rigorous scrutiny before researchers draw conclusions about how well they work.